Cyclosporine withdrawal improves long-term graft survival in renal transplantation

Transplantation

Volumn 87, Issue 12, 2009, Pages 1877-1883

  Gallagher, Martin ^a   Jardine, Meg ^a   Perkovic, Vlado ^a   Cass, Alan ^a   McDonald, Stephen ^b   Petrie, James ^c   Eris, Josette ^d  

^a GEORGE INSTITUTE FOR INTERNATIONAL HEALTH   (Australia)

^b QUEEN ELIZABETH HOSPITAL   (Australia)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

^d ROYAL PRINCE ALFRED HOSPITAL   (Australia)

Author keywords

Cyclosporine; Graft survival; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; METHYLPREDNISOLONE; PREDNISOLONE; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; AUSTRALIA; CADAVER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LEUKOPENIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEPHROTOXICITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; SURVIVAL;

AZATHIOPRINE; CAUSE OF DEATH; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLOMERULAR FILTRATION RATE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LIVER FUNCTION TESTS; MALE; NEOPLASMS; PATIENT SELECTION; PREDNISOLONE; SURVIVAL ANALYSIS; SURVIVORS;

EID: 67649586577     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e3181a76823     Document Type: Article

References (24)

1. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605.
2. Meier-Kriesche HU, Schold JD, Srinivas TR, et al. Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004; 4: 378.
3. McDonald S, Russ G, Campbell S, et al. Kidney transplant rejection in Australia and New Zealand: Relationships between rejection and graft outcome. Am J Transplant 2007; 7: 1201.
4. The Canadian Multicentre Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. Analysis at three years. N Engl J Med 1986; 314: 1219.
5. Ponticelli C, Minetti L, Di Palo FQ, et al. The Milan clinical trial with cyclosporine in cadaveric renal transplantation. A three-year followup. Transplantation 1988; 45: 908.
6. Merion RM, White DJ, Thiru S, et al. Cyclosporine: Five years' experience in cadaveric renal transplantation. N Engl J Med 1984; 310: 148.
7. National Institute of Diabetes and Digestive and Kidney Diseases. USRDS 2006 Annual Data Report: Atlas of End Stage Renal Disease in the United States. Bethesda, MD, US Renal Data System 2006.
8. Chadban S, McDonald S, Chang S, et al. Transplantation. In: McDonald S, Chang S, Excell L, eds. ANZDATA registry report 2006. Adelaide, South Australia, the Australia and New Zealand Dialysis and Transplant Registry 2006.
9. NationalInstituteofClinicalExcellence.Immunosuppressivetherapyforrenal transplantation in adults: Technology Appraisal 85. London, UK: National Institute of Clinical Excellence, 2004.
10. Vincenti F. Immunosuppression minimization: Current and future trends in transplant immunosuppression. J Am Soc Nephrol 2003; 14: 1940.
11. Morris PJ, French ME, Dunnill MS, et al. A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months. Transplantation 1983; 36: 273.
12. Novick AC, Hwei HH, Steinmuller D, et al. Detrimental effect of cyclosporine on initial function of cadaver renal allografts following extended preservation. Results of a randomized prospective study. Transplantation 1986; 42: 154.
13. Chapman JR, Marcen R, Arias M, et al. Hypertension after renal transplantation. A comparison of cyclosporine and conventional immunosuppression. Transplantation 1987; 43: 860.
14. Farnsworth A, Hall BM, Ng AB, et al. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Am J Surg Pathol 1984; 8: 243.
15. Nankivell BJ, Borrows RJ, Fung CL, et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326.
16. Bakker RC, Hollander AA, Mallat MJ, et al. Conversion from cyclosporine to azathioprine at three months reduces the incidence of chronic allograft nephropathy. Kidney Int 2003; 64: 1027.
17. Gallagher MP, Hall B, Craig J, et al. A randomized controlled trial of cyclosporine withdrawal in renal-transplant recipients: 15-year results. Transplantation 2004; 78: 1653.
18. Abramowicz D, Del Carmen Rial M, Vitko S, et al. Cyclosporine withdrawal from a mycophenolate mofetil-containing immunosuppressive regimen: Results of a five-year, prospective, randomized study. J Am Soc Nephrol 2005; 16: 2234.
19. Kasiske BL, Chakkera HA, Louis TA, et al. A meta-analysis of immunosuppression withdrawal trials in renal transplantation. J Am Soc Nephrol 2000; 11: 1910.
20. Hall BM, Tiller DJ, Hardie I, et al. Comparison of three immunosuppressive regimens in cadaver renal transplantation: Long-term cyclosporine, short-term cyclosporine followed by azathioprine and prednisolone, and azathioprine and prednisolone without cyclosporine. N Engl J Med 1988; 318: 1499.
21. Levey AS, Greene T, Kusek J, et al. A simplified equation to predict glomerular filtration rate from serum creatinine. J Am Soc Nephrol 2000;11: 155A.
22. Joss N, Rodger RS, McMillan MA, et al. Randomized study comparing cyclosporine with azathioprine one year after renal transplantation-15- year outcome data. Transplantation 2007; 83: 582.
23. US Renal Data System. USRDS 2007 annual data report: Atlas of end stage renal disease in the United States. Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases 2007, p 169.
24. Mayer AD. Chronic rejection and graft half-life: Five-year follow-up of the European Tacrolimus Multicenter Renal Study. Transplant Proc 2002; 34: 1491.